AXON Axon Enterprise, Inc.
Trend channel, buy level and 3-month target. Information only, not financial advice.
Below the channel · 2-year channel falling
Closed below support (US$540.96). Treat the buy level with caution.
- 2-year channel
- US$540.96 – US$623.28 · falling, −18% a year
- Price in channel
- −138% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$623.28
- Published levels
- Buy and target are not from this channel — see below.
What broke this trend
- The fall
- -60% from US$869.997 Aug 2025 → 10 Apr 2026
- Whose problem it was
- This company0 of 16 Aerospace & Defense peers fell with it
- Does it resolve?
- Temporary falls like it have resolved on the record
- Regained so far
- 18%of what it lost
- What the record says
- 63% of 14 comparable falls came back, typically in 83 days measured on its own peer group
Fell -60% (7 Aug 2025 → 10 Apr 2026); regained 18% so far; company-specific.
Reported at the time: Axon Enterprise Q2 Adj. EPS $2.12 Beats $1.46 Estimate, Sales $669.00M Beat $641.24M Estimate — 4 Aug 2025
Price history, with the path projected 3 months forward
Updated 9:10 PM ET (63 h ago)
- Daily close
- Upper trend line (2 years)
- Lower trend line (2 years)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy now
US$427.57
last close · 30 Oct 2026
Our target
US$503.88
by 15 Nov 2026
Projected move
17.8%
gross, before costs
Last close is our buy.
Target: AXON's usual move size.
This move size: reached in 58% of 11 past stretches, typically in 84 days. (0.18% per day)
- Upper line touches
- 6
- Lower line touches
- 3
- Fit confidence
- 50%
- Fitted
- 1 Nov 2026
Company information
About Axon Enterprise, Inc.
Axon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energy devices (CEDs) marketed under its well-known TASER brand, catering to both domestic and international clients. Axon's operations are divided into two primary segments: TASER, and Software and Sensors. In addition to its signature TASER devices, such as the TASER 7, X26P, X2, and consumer models, along with their corresponding cartridges, Axon offers an extensive portfolio of hardware and cloud-based software. These solutions are designed to equip law enforcement agencies with the means to capture, securely archive, manage, share, and analyze video and other digital evidence. Key products in this category include on-officer body cameras, Axon Fleet in-car systems, the Axon Evidence digital evidence management platform, Axon Signal-enabled devices, extended hardware warranties, and vital accessories like docks, cartridges, and batteries. Axon distributes its offerings through multiple channels, including its dedicated direct sales force, various distribution partners, its online storefront, and authorized third-party resellers. Furthermore, the company has established a strategic partnership with Fusus, Inc. to enhance the functionality of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution, providing agencies with real-time operational awareness and more efficient investigative processes.
- Sector
- Industrials
- Industry
- Aerospace & Defense
- CEO
- Patrick W. Smith
- Employees
- 5,100
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$35.59B
- Enterprise value
- —
- Beta
- 1.44
- Avg volume
- 994.84K
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 339.01-760.85
- Exchange
- NASDAQ
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.